Free Trial

This company has been marked as potentially delisted and may not be actively trading.

LogicBio Therapeutics (LOGC) Competitors

LogicBio Therapeutics logo

LOGC vs. MYTE, BWMX, VGII, OG, WNW, OGBLY, BBW, ETD, BH, and VLGEA

Should you be buying LogicBio Therapeutics stock or one of its competitors? The main competitors of LogicBio Therapeutics include MYT Netherlands Parent B.V. (MYTE), Betterware de México, S.A.P.I. de C.V. (BWMX), Virgin Group Acquisition Corp. II (VGII), Onion Global (OG), Meiwu Technology (WNW), Onion Global (OGBLY), Build-A-Bear Workshop (BBW), Ethan Allen Interiors (ETD), Biglari (BH), and Village Super Market (VLGEA).

LogicBio Therapeutics vs. Its Competitors

LogicBio Therapeutics (NASDAQ:LOGC) and MYT Netherlands Parent B.V. (NYSE:MYTE) are both small-cap retail/wholesale companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

MYT Netherlands Parent B.V. has a net margin of -3.98% compared to LogicBio Therapeutics' net margin of -141.03%. MYT Netherlands Parent B.V.'s return on equity of -5.88% beat LogicBio Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
LogicBio Therapeutics-141.03% -81.98% -52.13%
MYT Netherlands Parent B.V. -3.98%-5.88%-3.63%

MYT Netherlands Parent B.V. has a consensus target price of $14.00, indicating a potential upside of 90.48%. Given MYT Netherlands Parent B.V.'s stronger consensus rating and higher possible upside, analysts clearly believe MYT Netherlands Parent B.V. is more favorable than LogicBio Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LogicBio Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
MYT Netherlands Parent B.V.
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

46.1% of LogicBio Therapeutics shares are held by institutional investors. Comparatively, 10.1% of MYT Netherlands Parent B.V. shares are held by institutional investors. 8.1% of LogicBio Therapeutics shares are held by company insiders. Comparatively, 1.9% of MYT Netherlands Parent B.V. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

LogicBio Therapeutics has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Comparatively, MYT Netherlands Parent B.V. has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500.

In the previous week, LogicBio Therapeutics' average media sentiment score of 0.00 equaled MYT Netherlands Parent B.V.'saverage media sentiment score.

Company Overall Sentiment
LogicBio Therapeutics Neutral
MYT Netherlands Parent B.V. Neutral

MYT Netherlands Parent B.V. has higher revenue and earnings than LogicBio Therapeutics. MYT Netherlands Parent B.V. is trading at a lower price-to-earnings ratio than LogicBio Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LogicBio Therapeutics$287M0.67-$317M-$5.79-1.27
MYT Netherlands Parent B.V.$881.44M0.71-$26.95M-$0.43-17.09

Summary

MYT Netherlands Parent B.V. beats LogicBio Therapeutics on 10 of the 14 factors compared between the two stocks.

Get LogicBio Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LOGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LOGC vs. The Competition

MetricLogicBio TherapeuticsCatalog & mail IndustryRetail SectorNASDAQ Exchange
Market Cap$193.42M$262.59M$26.34B$9.01B
Dividend YieldN/A12.64%175.57%4.03%
P/E Ratio-1.272.2629.2120.17
Price / Sales0.6712.315.36124.64
Price / CashN/A58.4747.2757.86
Price / Book0.822.845.765.62
Net Income-$317M$4.74M$869.96M$248.50M

LogicBio Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LOGC
LogicBio Therapeutics
1.4281 of 5 stars
$7.36
-1.7%
N/A+32.3%$193.42M$287M-1.2762Gap Down
MYTE
MYT Netherlands Parent B.V.
N/A$7.90
-2.3%
$14.00
+77.2%
+63.7%$677.02M$881.44M-18.371,240
BWMX
Betterware de México, S.A.P.I. de C.V.
3.4984 of 5 stars
$8.60
-1.7%
N/A-29.8%$320.93M$14.00B6.141,270News Coverage
VGII
Virgin Group Acquisition Corp. II
N/A$1.10
-4.3%
N/A-31.6%$55.34MN/A0.00N/A
OG
Onion Global
N/AN/AN/AN/A$25.02M$2.04B0.00796
WNW
Meiwu Technology
N/A$1.95
+11.8%
N/A-87.1%$6.17M$158.49K0.0050Gap Up
OGBLY
Onion Global
N/AN/AN/AN/A$11KN/A0.00860
BBW
Build-A-Bear Workshop
2.0262 of 5 stars
$51.43
-5.0%
$51.33
-0.2%
+105.2%$714.98M$496.40M12.365,100
ETD
Ethan Allen Interiors
3.7993 of 5 stars
$27.85
-0.3%
$32.00
+14.9%
+9.2%$710.01M$646.22M12.383,404News Coverage
BH
Biglari
1.2963 of 5 stars
$291.92
+0.2%
N/A+59.6%$663.24M$362.11M-1.332,535High Trading Volume
VLGEA
Village Super Market
3.2994 of 5 stars
$38.50
-0.2%
N/A+43.6%$569.14M$2.24B10.167,300News Coverage
Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:LOGC) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners